Pharmaceutical companies have always been criticized for delaying or failing to develop appropriate formulations for HIV drugs. Internal documents of Gilead Sciences, one of the largest pharmaceutical companies in the world, show that it delayed the launch of a promising HIV drug in 2004 with the aim of extending the validity of its patents on a group of successful drugs, according to an investigation by the American New York Times.
2023-07-22 14:04:00
#Report #major #pharmaceutical #company #benefit #delaying #AIDS #treatment
Related posts:
Madrid's Successful RSV Vaccination Campaign Results in Major Reduction in Hospital Cases for Infant...
"Proxima b: The Nearest Earth-like Planet and Its Habitable Zone"
With the fluctuating weather and fall season… everything you need to know about the flu vaccine
the Sarlat hospital defense committee has been fighting for a decade
